[Refractory pain in children with cancer: role of peridural analgesia].

Abstract

BACKGROUND Adequate treatment of pain in children with cancer is a critical issue, and is of equal importance as discussions concerning chemotherapy, surgery and radiotherapy. OBJECTIVE To evaluate the treatment of refractory pain by peridural analgesia. METHODS Seven children (1-15 years) with solid tumors were treated with long term epidural analgesia for refractory pain. Catheters were inserted in epidural space (L1-L2) and infused with sufentanil, bupivacaine and clonidine. RESULTS Three out of five children with good response to peridural therapy could be discharged. A 12-month-old infant had a poor response. Treatment was discontinued in a teenager boy because of patient refusal. The side effects were: early catheter displacement in two patients and a bacterial contamination in one. Serious adverse effects related to high doses of opiates were not observed. However, toxicity of bupivacaine was observed in three patients leading to treatment discontinuation in one. CONCLUSION Long-term epidural analgesia looks promising in selected children with refractory pain.

Cite this paper

@article{Portas1998RefractoryPI, title={[Refractory pain in children with cancer: role of peridural analgesia].}, author={Matt Portas and Julia Marty and C Buttin and J. C. Gentet and Carole Coze and K Fallouh and J. L. Bernard and Jean Camboulives}, journal={Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie}, year={1998}, volume={5 8}, pages={851-60} }